“…Various studies have evaluated the potential role of various inflammatory cytokines and acute-phase reactants as biomarkers of TB-IRIS and the findings, though encouraging, are not concrete enough to be considered clinically useful now. Elevated levels of CRP, IL-6, IL-18, IP-10, IL-33, IFN-γ, and sCD14 individually or in combination have been investigated extensively as predictors for paradoxical TB-IRIS [ 15 , 50 , 57 , 58 , 59 , 60 ]. A prospective observational study from Botswana evaluated 26 plasma biomarkers in baseline specimens and revealed an association between TB-IRIS and lower growth factors such as IL-3, Th1 cytokine responses and low levels of IL-17 [ 16 ].…”